Lisa J. Schlein

Magic Eye: Karkinos emerging from the deep

Lisa J. Schlein, 2017 .

In-vitro effects of taurolidine alone and in combination with mitoxantrone and/or piroxicam on canine transitional cell carcinoma.

Lisa J. Schlein, B. Séguin, B. Rose, 2020, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.

Synergistic and targeted therapy with a procaspase-3 activator and temozolomide extends survival in glioma rodent models and is feasible for the treatment of canine malignant glioma patients

Lisa J. Schlein, M. Podell, G. Riggins, 2017, Oncotarget.

Immunohistochemical Characterization of Procaspase-3 Overexpression as a Druggable Target With PAC-1, a Procaspase-3 Activator, in Canine and Human Brain Cancers

Lisa J. Schlein, C. Eberhart, T. Fan, 2019, Front. Oncol..

Review: NF-kB activation in canine cancer

Lisa J. Schlein, D. Thamm, L. Schlein, 2022, Veterinary pathology.

Immunohistochemical evidence of NF-kB activation in canine lymphomas, histiocytic sarcomas, hemangiosarcomas, and mast cell tumors.

Lisa J. Schlein, D. Thamm, 2023, Veterinary pathology.